Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 282 participants.
Also called NCT06744361
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 282 participants
- Sponsor
- Registry
-
NCT06744361 -
2024-515987-29-00
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Recruiting
Technical summary
Registry record NCT06744361. Randomized; quadruple masking; primary purpose treatment. Start 2024-12-12 (actual); primary completion 2027-09-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest
- Acronym
- KETOHCA
- Condition
- Out-of-hospital Cardiac Arrest (OHCA)
- Intervention (Drug)
- esketamine hydrochloride
- Intervention (Drug)
- propofol
- Lead sponsor
- Christian Hassager
Record details
- Record id
cardio:ct-nct06744361- Content hash
0a6fc26334715c5bb0132e7ba31a466a97c237d84c19232c81ea9a3fc196aaff